3 results
Approved WMORecruiting
To compare the overall survival of patients with relapsed or refractory GCT treated with conventional-dose chemotherapy using the TIP regimen (CDCT) with patients treated with high-dose chemotherapy (HDCT) plus ASCT using the TI-CE regimen as…
Approved WMOWill not start
To assess the safety and reactogenicity of HB-101.To assess the immunogenicity of HB-101.
Approved WMOCompleted
In this feasibility study, we will validate the value of the preoperative [89Zr]trastuzumab PET/CT imaging to identify HER2 positive primary breast cancer and the possibility to predict pathological complete response.